Gabelli Funds LLC Has $20.36 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Gabelli Funds LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,975 shares of the healthcare conglomerate’s stock after selling 735 shares during the quarter. Gabelli Funds LLC’s holdings in UnitedHealth Group were worth $20,358,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the company. Bell Investment Advisors Inc lifted its stake in UnitedHealth Group by 4.8% in the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after acquiring an additional 24 shares in the last quarter. Harbor Investment Advisory LLC grew its position in UnitedHealth Group by 3.2% during the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after purchasing an additional 1,129 shares in the last quarter. Austin Private Wealth LLC boosted its stake in shares of UnitedHealth Group by 9.8% during the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after buying an additional 111 shares during the period. Capital Insight Partners LLC raised its holdings in shares of UnitedHealth Group by 3.8% during the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock worth $4,475,000 after acquiring an additional 332 shares in the last quarter. Finally, Collective Family Office LLC grew its stake in UnitedHealth Group by 4.3% in the first quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock valued at $780,000 after purchasing an additional 65 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

UnitedHealth Group Stock Down 0.4 %

Shares of UNH opened at $575.00 on Monday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94. The firm has a market capitalization of $529.22 billion, a P/E ratio of 35.15, a P/E/G ratio of 1.64 and a beta of 0.58. The company has a 50-day simple moving average of $577.10 and a 200-day simple moving average of $521.14. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same period in the previous year, the business posted $6.14 earnings per share. UnitedHealth Group’s quarterly revenue was up 6.4% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Analyst Upgrades and Downgrades

UNH has been the subject of several recent research reports. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and increased their price target for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Royal Bank of Canada boosted their price target on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Finally, Argus boosted their target price on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.